![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 40, 37881-37887, October 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
, and
From the Department of Cellular and Molecular Physiology, Yale
University School of Medicine, New Haven, Connecticut 06520-8026, the
Department of Molecular Genetics, Biochemistry, and
Microbiology, University of Cincinnati College of Medicine,
Cincinnati, Ohio 45267-0524, § Laboratory of Kidney and
Electrolyte Metabolism, NHLBI, National Institutes of Health,
Bethesda, Maryland 20892, and the ¶ Department of Pharmacology,
New York Medical College, Valhalla, New York 10595
Received for publication, July 3, 2002, and in revised form, July 17, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The ROMK (Kir1.1; Kcnj1)
gene is believed to encode the apical small conductance K+
channels (SK) of the thick ascending limb (TAL) and cortical collecting
duct (CCD). Loss-of-function mutations in the human ROMK gene cause
Bartter's syndrome with renal Na+ wasting, consistent with
the role of this channel in apical K+ recycling in the TAL
that is crucial for NaCl reabsorption. However, the mechanism of renal
K+ wasting and hypokalemia that develop in individuals with
ROMK Bartter's syndrome is not apparent given the proposed loss of the
collecting duct SK channel. Thus, we generated a colony of ROMK null
mice with ~25% survival to adulthood that provides a good model for
ROMK Bartter's syndrome. The remaining 75% of null mice die in less
than 14 days after birth. The surviving ROMK null mice have normal
gross renal morphology with no evidence of significant hydronephrosis,
whereas non-surviving null mice exhibit marked hydronephrosis. ROMK
protein expression was absent in TAL and CCD from null mice but
exhibited normal abundance and localization in wild-type littermates.
ROMK null mice were polyuric and natriuretic with an elevated
hematocrit consistent with mild extracellular volume depletion. SK
channel activity in TAL and CCD was assessed by patch clamp analysis in
ROMK wild-type ROMK(+/+), heterozygous ROMK(+/ The kidney small conductance K+ channel
(SK)1 expressed in the apical
membranes of thick ascending limb (TAL) and cortical collecting duct
(CCD) cells mediates K+ secretion in the distal nephron,
thereby playing an essential role in K+ balance (1). In the
TAL, the SK channel mediates K+ recycling across the apical
membrane that is essential for maintaining the supply of luminal
K+ for Na-K-2Cl cotransport (2-5). In the principal cells
of the CCD, the SK channel provides a major pathway for apical
K+ secretion.
ROMK (Kir1.1; gene locus, Kcnj1), cloned from rat kidney
outer medulla (6), is a member of the inward rectifier (Kir) family of
K+ channels (7). Several lines of evidence have suggested
that ROMK may encode the SK channel. First, there are several
NH2-terminal alternative splice variants of rodent (6,
8-10) and human (11) ROMK that are differentially expressed along the
distal nephron segments where SK channels have been observed (9, 10).
Second, ROMK protein has been immunolocalized to apical membranes of
the nephron segments expressing the various ROMK transcripts (12-14). Finally, ROMK shares many functional and regulatory properties with
native SK channels (15, 16). They have similar single channel kinetics
including low channel conductance, high open probability, one open time
and one closed time (6, 14, 16). Moreover, they are similarly regulated
by channel phosphorylation and dephosphorylation processes (17, 18),
cytosolic pH (19, 20), and tyrosine kinases that are modulated by
dietary K+ intake (21-23).
Bartter's syndrome comprises a set of genetically heterogeneous
disorders characterized by salt wasting and polyuria-associated low
blood pressure and hypokalemic alkalosis (24-27). Molecular genetic
studies have identified loss-of-function mutations in any one of four
genes encoding transporters mediating salt absorption by the TAL
(28-31). Mutations in the apical Na-K-2Cl cotransporter (NKCC2) (32)
and basolateral Cl In the present study, we assessed the expression of SK channel by patch
clamping in TAL and CCD from ROMK null mice. Given the low survival and
hydronephrosis of the original ROMK null mice (69), which would
have presented difficulties in obtaining tubules for patch clamping, we
developed a ROMK null mouse with high survival and normal histology by
crossing surviving ROMK null mutants with heterozygotes from litters in
which there were surviving null mutants. These mice exhibited
characteristics of Bartter's syndrome including polyuria,
Na+ and K+ wasting. Kidney morphology in the
ROMK null mice was normal without finding of hydronephrosis, and ROMK
protein expression in TAL and CCD was absent.
K+ channel activity was absent in apical membranes from
either TAL or CCD from ROMK( Breeding and Genotyping--
The generation of the ROMK null
mice is described in the accompanying article (69). Initially,
surviving null ROMK( Immunocytochemistry and Morphology Studies--
ROMK(+/+),
ROMK(+/ Metabolic Balance--
ROMK(+/+) and ROMK( Patch Clamping--
Experiments were performed in mice between 2 and 5 weeks after birth. The left kidney was removed following
anesthesia by intraperitoneal injection of pentobarbital sodium (0.1 mg/g body wt). 4-5 TAL and CCD tubules were microdissected from each
mouse for apical patch clamping as described previously (47). All experiments were carried out at room temperature (22-24 °C).
Bath and tubule dissection solutions contained (mM) 140 NaCl, 5 KCl, 1.8 MgCl2, 1.8 CaCl2, and 10 HEPES
(pH 7.4 adjusted with NaOH). For the inside-out patch configuration,
the bath solution was the same as the dissection solution except for
0.8 MgCl2, 0 CaCl2, 1 EGTA. 0.5 mM
MgATP (Sigma) was added to the bath to keep channels from running down.
The pipette solution contained (mM) 140 KCl, 1.8 MgCl2 and 10 HEPES (pH 7.4 adjusted with KOH).
Single channel activity was recorded in both cell-attached and
inside-out configurations as reported previously (47). For analysis,
current recordings were from inside-out patches with a pipette holding
potential ( Statistics--
Data are presented as means ± S.E. Two-way
Student's t test was used to compare control and
experimental groups. The difference between the mean values of
ROMK(+/+) and ROMK( ROMK-deficient Mice with Increased Survival without Severe
Hydronephrosis--
Companion studies by Lorenz et al. (69)
showed that the mortality of ROMK-deficient mice was very high with
less than 5% survival to weaning at 21 days. These ROMK(
Fig. 2 shows the gross morphology of
kidneys obtained from wild-type ROMK(+/+), heterozygous (ROMK(+/ Expression of ROMK Protein in TAL and CCD Is Absent in ROMK( ROMK-deficient Mice Have Polyuria, Increased Na+ and
K+ Excretion with Mild Volume Depletion, but No Hypokalemia
and a Normal Acid-base State--
Table
I shows the plasma Na+,
Cl
The results of metabolic studies, shown in Tables
III and IV,
demonstrate that the 24-h urine volumes and urinary Na+ and
K+ excretion rates were significantly higher in ROMK null
mice compared with wild-type mice. The polyuria in the ROMK( SK Channel Activity Is Absent in ROMK(
A total 313 of patches with successful seals was obtained in the three
ROMK genotypes. Wild-type ROMK(+/+) mice showed SK channel activity in
18 of 27 patches (66.67%) in TAL and 14 of 24 patches (58.33%) in
CCD. This is consistent with the lower density of SK channels in the
mouse compared with that in the rat (49). Functional expression of SK
channels in TAL and CCD in wild-type ROMK(+/+) mice was observed as
early as 2 weeks. SK channel activity in ROMK heterozygous mice was
about half that of the wild-type, 38% (20 of 52 patches) in TAL and
25% (21 of 83 patches) in CCD. In contrast, no SK channel activity was
observed at any age in ROMK null mice (n = 15 mice,
total of 61 and 66 patches) in either TAL or CCD (data summarized in
Table VI). Neither intermediate (70 pS)
nor large conductance K+ channels (~150 pS) were observed
in our wild-type mice using our current patch conditions.
Selective breeding of ROMK-deficient mice resulted in development
of a colony without (or significantly reduced) hydronephrosis but
displaying some of the characteristics of human Bartter's syndrome
including polyuria with increased urinary Na+ loss and mild
extracellular fluid volume depletion. The increased urinary
Na+ loss and low urine osmolality in these ROMK-deficient
mice are consistent with dysfunction of NaCl handling by the TAL as
demonstrated in the accompanying article (69) and in human Bartter's
syndrome (50, 51).
The ROMK-deficient mice did not develop hypokalemia (Table I) as seen
in human Bartter's syndrome and in NKCC2-deficient mice (48), but did,
however, exhibit a high 24-h urinary K+ excretion in the
steady state (Table II). Increased fluid and Na+ delivery
to the rat CCD, as may occur by reducing NaCl reabsorption by
furosemide-mediated inhibition of NKCC2 in the TAL, promotes K+ secretion and urinary K+ loss (52, 53).
However, the loss of SK activity in principal cells may have limited
the magnitude of kaliuresis in ROMK-deficient mice despite increased
Na+ and fluid delivery to the CCD. In addition, the adult
ROMK null mice did not develop metabolic alkalosis as is also typical
for human Bartter's syndrome (50, 51). This may reflect the fact that
ROMK( By using the patch clamp technique, we showed that the biophysical
properties of SK channels in TAL and principal cells from our mouse
colony (Table IV) are similar to that of SK channels observed
previously in the rat (1, 16, 54-56) and mouse (47) and to ROMK
expressed in Xenopus oocytes (8, 16, 57). In the rat,
postnatal ROMK transcript and protein expression have been observed as
early as 1 week in the medullary TAL and is clearly expressed by 3 weeks in cortical TAL and CCD (58). If a similar post-natal expression
pattern occurs in the mouse, then the absence of SK channel activity in
TAL and CCD from ROMK-deficient mice at 3-5 weeks (Table V)
establishes that ROMK is essential for functional expression of SK
channels involved in K+ recycling in the TAL and in
K+ secretion in principal cells. Heterozygous ROMK(+/ Two types of K+ channels have been described in apical
membranes of the rat (59) and mouse (47, 49) TAL: a small conductance K+ channel (SK, ~30 pS) and an intermediate conductance
K+ channel (~70 pS). A third type of calcium-activated
large conductance K+ channel (~150 pS) has also been
observed in mouse TAL cells and in cultured rabbit TAL cells (60). It
is generally believed that the 30- and 70-pS channels are involved in
K+ recycling in the TAL, whereas the large conductance
K+ channel may be involved in cell volume regulation (15,
49). In the rat TAL, 60-80% of the total apical K+
conductance is contributed by the 70-pS K+ channel (49, 61,
62), although the contribution of this intermediate conductance
K+ channel to total apical K+ conductance in
the mouse appears to be somewhat lower (49). We do not know if human
TAL cells express the 70-pS K+ channel or the potential
contribution of this channel to total apical membrane K+
conductance in this TAL segment. However, by assuming that 60-80% of
apical conductance is mediated by the 70-pS K+ channel in
the human TAL, loss of the SK channel should only modestly affect TAL
function unless ROMK were necessary for functional expression of the
intermediate conductance K+ channel (15, 49). In our
experiments, we did not observe the intermediate conductance
K+ channel in TAL from wild-type or ROMK-deficient mice. It
should be noted, however, that our experimental conditions were
optimized for observation of the SK channel in the wild-type mice.
Additional studies will be required to address the role of ROMK in the
70-pS channel where we have optimized the activity of the 70-pS channel in wild-type mouse controls (e.g. high K+ diet).
Two types of K+ channels have also been observed in apical
membranes of principal cells in rat (63, 64) and
mouse2 CCD as follows: a
small conductance K+ channel (SK, 30 pS) and a
calcium-activated large conductance K+ channel (150 pS).
The large conductance K+ channel has been suggested to
mediate flow-dependent K+ secretion by
principal cells (65, 66). Under our experimental conditions, we did not
observe the large conductance K+ channel in principal cells
from ROMK-deficient mice. Again, it is possible that our patch
conditions were not conducive to observe the Ca2+-activated
large conductance K+ channel because the bath solution did
not contain Ca2+.
One of the phenotypic characteristics of Bartter's syndrome is
hypokalemia. In our ROMK(
), and null ROMK(
/
)
mice. In 313 patches with successful seals from the three ROMK
genotypes, SK channel activity in ROMK (+/+ and +/
) exhibited normal
single channel kinetics. The expression frequencies are as follows: 67 (TAL) and 58% (CCD) in ROMK(+/+); about half that of the wild-type in ROMK(+/
), being 38 (TAL) and 25% (CCD); absent in both TAL or CCD in
ROMK(
/
) between 2 and 5 weeks in 15 mice (61 and 66 patches, respectively). The absence of SK channel activity in ROMK null mice
demonstrates that ROMK is essential for functional expression of SK
channels in both TAL and CCD. Despite loss of ROMK expression, the
normokalemic null mice exhibited significantly increased kaliuresis, indicating alternative mechanisms for K+
absorption/secretion in the nephron.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
channel
- (CLCNKB (33)) or
-subunits (barttin (34, 35)) result in Bartter's syndrome by
disrupting the pathway for NaCl transport in the TAL. In addition, null
mutations in ROMK also give rise to the Bartter's phenotype consistent
with a role for this K+ channel in TAL function (36-38).
The Bartter's mutations in ROMK have been shown to reduce
K+ channel expression or function (39-42), consistent with
the necessity of this channel for normal salt reabsorption in the TAL.
However, the characteristic hypokalemia in individuals with ROMK
Bartter's is difficult to explain on the basis of loss of ROMK
function if this channel encodes the SK channel in CCD.
/
) mice, whereas wild-type ROMK(+/+) littermates exhibited normal SK activity. The percent of successful patches in TAL or CCD showing SK channel activity in heterozygous ROMK(+/
) mice was ~50% of that in ROMK(+/+) littermates. These results demonstrate that ROMK encodes the SK channel in apical membranes of both TAL and CCD principal cells.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
) males were bred with heterozygous females to
enhance survival. ROMK(+/
) heterozygous breeding pairs from these
survivors were intercrossed for several generations to develop a new
colony. All mice were maintained on standard mouse chow and tap water. Pups were genotyped 7 days after birth by PCR using DNA extracted from
tail biopsies. The wild-type gene was amplified using a forward primer
(5'-GTGACAGAACAGTGTGCC-3') corresponding to codons 149-154 and a
reverse primer (5'-CTCCTTCAGGTGTGATGG-3') corresponding to anticodons
240-234. The mutant gene was amplified using the reverse primer from
the ROMK gene and a primer (5'-CTGACTAGGGGAGGAGTAGAAGG-3') complementary to sequences in the 5'-untranslated region of the neo gene.
), and ROMK(
/
) mice were anesthetized by pentobarbital
(0.1 mg/g body wt) and perfused via the aorta with Hanks' solution,
with drainage from the inferior vena, until the kidneys blanched. The
mice were perfusion-fixed with 2% paraformaldehyde, 75 mM
lysine, 10 mM sodium periodate (PLP). The kidneys were
removed and transferred into 10% sucrose buffer overnight before
cutting. Frozen sections (1 or 10 µm) were processed for
immunofluorescence histochemistry with antibody labeling (43, 44).
Sections were incubated for 16-18 h at 4 °C with primary antibody
(rabbit anti-rat ROMK produced by amino acids 370-391 in ROMK1
(45)) diluted 1:250 in phosphate-buffered saline, 0.3% Triton X-100,
0.1% bovine serum albumin, 10% goat serum. After washing 3 times with
Tris-buffered saline, the sections were incubated for 1-2 h with goat
anti-rabbit Alexa Fluor 488 (IgG (1:200) from Molecular Probes, Eugene,
OR). Controls with omission of primary antibody showed no significant fluorescence.
/
) mice were
housed in metabolic cages obtained from Lab Products Inc, Seaford, DE.
Two mice from same litter of similar genotype were housed in a single
cage to ensure normal eating and drinking behavior. After 2 days of
training in the cage, 24-h food and water intake and urine output were measured and recorded. All data represent the average of three 24-h
values. Urinary Na+ and K+ concentrations were
measured by a flame photometer, and daily Na+ and
K+ excretion was calculated as mEq/24 h. Na+,
Cl
, and K+ concentrations were also measured
in plasma from retro-orbital bleeds by a Corning Blood Gas analyzer
(46). Blood gas analysis was performed on freshly drawn blood and
measured by a Corning Blood Gas Analyzer.
V) of
40 mV. Channel open time (To), closed time (Tc), and
open probability (Po) were calculated over
4 s with a filter frequency of 250 Hz using pCLAMP software,
version 6.0.5 of Fetchan and pSTAT (Anxon Instrument, Inc.). Channel
conductance was calculated from current-voltage (I-V) curves between
40 and
80 mV.
/
) groups was considered significant at
p < 0.05.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
) mice
had renal insufficiency with profound hydronephrosis. We developed a
colony with increased survival by selectively crossing surviving ROMK null mice with heterozygotes from litters in which there were surviving
null mutants. As shown in Fig. 1, 25% of
ROMK(
/
) mice survived to adulthood, and the remaining mice died
before 14 days. There was no difference in survival rate between the
wild-type ROMK(+/+) and heterozygous ROMK(+/
) mice.

View larger version (19K):
[in a new window]
Fig. 1.
Survival rates of ROMK wild-type ROMK(+/+),
heterozygous ROMK(+/
), and null
ROMK(
/
) mice. The
percentage of survival was analyzed by the ratio of the animal numbers
at birth (day 1) and the number of survivors at subsequent days.
),
and null (ROMK(
/
) mice that either survived or did non-survive
beyond 14 days. In non-surviving ROMK(
/
) mice, the size of the
kidney was about one-third of normal (Fig. 2, E and
F); the renal cortex was considerably thinner than in
wild-type (Fig. 2, A and B) or heterozygous (Fig. 2, C and D) mice, and the renal pelvis
surrounding the renal papilla and the pelvic fornices at the level of
the outer medulla were extensively dilated. These changes indicated
that significant hydronephrosis was present in the non-surviving null
mice, but this was still somewhat milder than that seen in the original ROMK-deficient mice (69). In contrast, the surviving null mice did not
have significant hydronephrosis, and the kidneys were only slightly
smaller than those from wild-type (Fig. 2, A and B) or heterozygous (Fig. 2, C and D)
mice. We cannot exclude the possibly that mild hydronephrosis may be
present in a small number of our ROMK(
/
) mice given the limited
number of animals examined in this study. There were no gross
histological difference among the ROMK(+/+), ROMK(+/
) and surviving
ROMK(
/
) mice (Fig. 2).

View larger version (111K):
[in a new window]
Fig. 2.
Kidney morphology in ROMK(+/+)
wild-type (A and B),
ROMK(+/
) heterozygous (C and
D),
ROMK(
/
) null
non-survivor (E and F), and survivor
(G and H) mice. Whole kidney
images (A, C, E, and G) are
at ×10, and detailed images (B, D, F,
and H) are at ×400. Sections are 10 µm thick and stained
with Richardson solution containing a 1:1 mixture of Azure II and
methylene blue. * in E indicates extensively dilated
pelvic fornices at the level of the outer medulla.
/
)
Mice--
To confirm the absence of ROMK expression in kidney in our
ROMK(
/
) genotype, we examined the expression and localization of
ROMK in wild-type and null mouse kidneys by immunofluorescence using a
polyclonal rabbit anti-rat antibody directed against a COOH-terminal
peptide (45). Fig. 3 shows paired phase
and immunofluorescence images of ROMK staining in 1-µm cryosections
of kidney cortex from ROMK(+/+) and ROMK(
/
) mice. ROMK was clearly
expressed at apical borders of the TAL and CCD segments in cortical
medullary rays. In contrast, there was no immunostaining of ROMK in
null mice in either the TAL or the collecting duct, confirming the ROMK(
/
) genotype generated as described in the accompanying article
(69).

View larger version (149K):
[in a new window]
Fig. 3.
ROMK is absent in
ROMK(
/
) null mice.
Matching phase (A and C) and immunofluorescence
images (B and D) of ROMK(+/+) wild-type
(A and B) and ROMK(
/
) null (C and
D) mice are shown. 1-µm sections were incubated with
rabbit anti-ROMK polyclonal antibody and Alexa Fluor 488 goat
anti-rabbit IgG. All images are at ×400 magnification.
PT, proximal tubule.
, and K+ concentrations measured in adult
ROMK(+/+) and ROMK(
/
) mice. Plasma Na+,
Cl
, and K+ in ROMK null mice were within the
physiological range and similar to wild-type values. Table
II shows the acid-base status in ROMK wild-type, heterozygous, and knockout mice from ~2-week-old pups and
adult mice. The 2-week-old animals included both surviving and
non-surviving pups. A slight metabolic acidosis was seen in the
ROMK null pups compared with either ROMK(+/+) of ROMK(+/
) mice.
However, no significant abnormality in acid-base status was observed in
adult ROMK null mice.
Plasma Na+, K+, CI
and hematocrit in ROMK
wild-type and knockout mice
Acid-base Status in ROMK wild-type and mutant mice
/
) mice
was associated with a significant reduction in urine osmolality
compared with the ROMK(+/+) mice (Table III). Daily water and food
intake were also increased in the ROMK(
/
) mice. The hematocrit was
significantly higher in ROMK null mice (Table I) suggesting mild
hypovolemia consistent with the polyuria and natriuresis. The magnitude
of the increase in hematocrit in the ROMK(
/
) mice was far less than
seen in the NKCC2(
/
) knockout reported previously by Takahashi et al. (48), consistent with the less severe polyuria and
dehydration in our ROMK knockout. Thus, the ROMK(
/
) mice exhibited
polyuria and salt wasting, consistent with a Bartter's type TAL
tubulopathy.
Urine volume, ENa, EK, and osmolality in ROMK knock-out and wild-type
mice
Body weight, food, and water intake in ROMK knockout and wild-type mice
/
) Mice--
Typical SK
channels were observed in 11 wild-type and 19 heterozygous mice between
2 and 5 weeks after birth. Fig. 4,
A and C, shows representative single SK channel
recordings in wild-type TAL and CCD using the inside-out configuration
at different pipette holding voltages. With 140 mM KCl in
the pipette and 140 mM NaCl + 5 mM KCl in bath,
I-V plots showed slightly inward-rectified currents (Fig. 4,
B and D). Channel conductance (G = ~31 pS) was calculated from the I-V curve between
40 and
80 mV
in the inside-out configuration. There were no differences
in the channel conductance between SK channels in the TAL or CCD
obtained from wild-type or heterozygous mice. SK channels had a high
open probability (Po = 0.88~0.89) in both TAL
and CCD with one open time and one closed time in inside-out
configuration at a pipette holding potential (
V) of
40
mV. The data are summarized in Table
V.

View larger version (33K):
[in a new window]
Fig. 4.
Representative single channel currents were
recorded from wild-type mice TAL (A) and CCD
(C) in inside-out configuration with 140 mM KCl in the pipette and 140 mM NaCl, 5 mM KCl in the bath. The different pipette holding
potentials (
V) were indicated on each left side of
tracings. B and D are the SK channel I-V curves
in TAL and CCD in the same experimental conditions in which the channel
showed slightly inward-rectified current, respectively. O
and C represent the channel open and closed
states.
SK channel kinetics in ROMK wild-type (+/+) and heterozygous
(+/
) mice
40 and
80 mV. All the data were calculated from inside-out
configuration with 140 mM KCl in the pipette and 140 mM NaCl, 5 mM KCl in the bath. Pipette holding
potential (
V) was
40 mV. Channel conductance (G) was
calculated between 0 and
80 mV.
Patches showing SK channel activity in ROMK wild-type (+/+),
heterozygous (+/
), and null (
/
) mice
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
) mice did not develop hypokalemia which would contribute to
the development and maintenance of hypokalemia. The 2-week-old ROMK
null pups had a mild metabolic acidosis because of the inclusion of
both pups with and without hydronephrosis (Fig. 2). The pups with
hydronephrosis would ultimately die before weaning with the metabolic
acidosis most likely being due to the loss of functioning renal mass.
Metabolic acidosis was also observed in the original ROMK(
/
) mice
exhibiting hydronephrosis reported in the accompanying article
(69).
)
mice expressed about 50% of the frequency of active channels compared
with the wild-type ROMK(+/+) controls (Table V) consistent with one
active allele.
/
) mice the plasma potassium concentration was normal (Table I), yet K+ excretion rate was
significantly elevated (Table II) and accompanied by increased food
intake (Table III). Interestingly, this enhanced potassium excretion in
ROMK(
/
) mice occurred in the absence of SK channel activity in the
CCD, indicating that alternative mechanisms for urinary K+
excretion are present. Several factors may contribute to the K+ loss seen in ROMK null mice. These include the
following: 1) diminished reabsorption of K+ in the TAL due
to loss K+ recycling required for Na-K-2Cl function, for
example, administration of furosemide leads to a reduction in
K+ reabsorption by the TAL, significant increase of
K+ delivery into the distal convoluted tubule, and
kaliuresis (67); 2) K+ secretion by
flow-dependent, Ca2+-activated K+
channels in the CCD (65, 66); 3) K+ secretion via apical
KCl cotransport in the CCD (68); 4) augmented paracellular
K+ back-leak into the CCD by increased aldosterone and the
consequent increase in lumen negativity; and 5) the presence of other
K+ transporters or channels. The ROMK-deficient mice
characterized in this study should provide an excellent model for
determining which mechanisms account for urinary K+ loss in
the absence of SK channels as well as for understanding the other
pathophysiology of renal K+ and Na+ handling in
Bartter's syndrome.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Michael Kashgarian, DeRen Shao, and Sue-Ann Mentone for the technical assistance with kidney morphology and antibody staining.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants DK54999 (to S. C. H.), DK54998 (to G. G.), DK54983 (to W. W.), and DK50594 (to G. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
** To whom correspondence should be addressed. E-mail: steven.hebert@yale.edu.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.M206644200
2 M. Lu, W.-H. Wang, G. Giebisch, and S. C. Hebert, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SK, small conductance K+ channel; CCD, cortical collecting duct; TAL, thick ascending limb; NKCC2, Na-K-2Cl cotransporter.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Giebisch, G. (1998) Am. J. Physiol. 274, F817-F833[Medline] [Order article via Infotrieve] |
| 2. | Greger, R., and Schlatter, E. (1981) Pfluegers Arch. 392, 92-94[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Greger, R., Bleich, M., and Schlatter, E. (1991) Kidney Int. 40 Suppl. 33, 119-124 |
| 4. | Hebert, S. C., and Andreoli, T. E. (1984) Am. J. Physiol. 246, F745-F756[Medline] [Order article via Infotrieve] |
| 5. |
Hebert, S. C.,
and Andreoli, T. E.
(1986)
J. Gen. Physiol.
87,
567-590 |
| 6. | Ho, K., Nichols, C. G., Lederer, W. J., Lytton, J., Vassilev, P. M., Kanazirska, M. V., and Hebert, S. C. (1993) Nature 362, 31-38[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Nichols, C. G., and Lopatin, A. N. (1997) Annu. Rev. Physiol. 59, 171-191[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Zhou, H., Tate, S. S., and Palmer, L. G. (1994) Am. J. Physiol. 266, C809-C824[Medline] [Order article via Infotrieve] |
| 9. | Boim, M. A., Ho, K., Shuck, M. E., Bienkowski, M. J., Block, J. H., Slightom, J. L., Yang, Y., Brenner, B. M., and Hebert, S. C. (1995) Am. J. Physiol. 268, F1132-F1140[Medline] [Order article via Infotrieve] |
| 10. | Lee, W.-S., and Hebert, S. C. (1995) Am. J. Physiol. 268, F1124-F1131[Medline] [Order article via Infotrieve] |
| 11. |
Shuck, M. E.,
Block, J. H.,
Benjamin, C. W.,
Tsai, T.-D.,
Lee, K. S.,
Slightom, J. L.,
and Bienkowski, M. J.
(1994)
J. Biol. Chem.
269,
24261-24270 |
| 12. | Xu, J. Z., Hall, A. E., Peterson, L. N., Bienkowski, M. J., Eessalu, T. E., and Hebert, S. C. (1997) Am. J. Physiol. 273, F739-F748[Medline] [Order article via Infotrieve] |
| 13. | Kohda, Y., Ding, W., Phan, E., Housini, I., Wang, J., Star, R. A., and Huang, C. L. (1998) Kidney Int. 54, 1214-1223[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Mennitt, P. A., Wade, J. B., Ecelbarger, C. A., Palmer, L. G., and Frindt, G. (1997) J. Am. Soc. Nephrol. 8, 1823-1830[Abstract] |
| 15. | Wang, W., Hebert, S. C., and Giebisch, G. (1997) Annu. Rev. Physiol. 59, 413-436[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Palmer, L. G., Choe, H., and Frindt, G. (1997) Am. J. Physiol. 273, F404-F410[Medline] [Order article via Infotrieve] |
| 17. |
Xu, Z. C.,
Yang, Y.,
and Hebert, S. C.
(1996)
J. Biol. Chem.
271,
9313-9319 |
| 18. |
McNicholas, C. M.,
Wang, W., Ho, K.,
Hebert, S. C.,
and Giebisch, G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8077-8081 |
| 19. | Choe, H., Zhou, H., Palmer, L. G., and Sackin, H. (1997) Am. J. Physiol. 273, F516-F529[Medline] [Order article via Infotrieve] |
| 20. | Fakler, B., Schultz, J. H., Yang, J., Schulte, U., Brändle, U., Zenner, H. P., Jan, L. Y., and Ruppersberg, J. P. (1996) EMBO J. 15, 4093-4099[Medline] [Order article via Infotrieve] |
| 21. |
Moral, Z.,
Dong, K.,
Wei, Y.,
Sterling, H.,
Deng, H.,
Ali, S., Gu, R.,
Huang, X. Y.,
Hebert, S. C.,
Giebisch, G.,
and Wang, W. H.
(2001)
J. Biol. Chem.
276,
7156-7163 |
| 22. |
Wei, Y.,
Bloom, P., Gu, R.,
and Wang, W.
(2000)
J. Biol. Chem.
275,
20502-20507 |
| 23. | Wang, W., Lerea, K. M., Chan, M., and Giebisch, G. (2000) Am. J. Physiol. 278, F165-F171 |
| 24. | Bartter, F. C., Pronove, P., Gill, J. R., Jr., MacCardle, R. C., and Diller, E. (1962) Am. J. Med. 33, 811-828[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Gill, J. R., Jr. (1980) Annu. Rev. Med. 31, 405-419[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Stein, J. H. (1985) Kidney Int. 28, 85-93[Medline] [Order article via Infotrieve] |
| 27. | Gordon, J. A., and Stokes, J. B. I. (1994) Hosp. Pract. 29, 103-108 |
| 28. | Guay-Woodford, L. M. (1998) Am. J. Med. 105, 151-161[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Karolyi, L., Koch, M. C., Grzeschik, K. H., and Seyberth, H. W. (1998) J. Mol. Med. 76, 317-325[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Asteria, C. (1997) Eur. J. Endocrinol. 137, 613-615[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Simon, D. B., and Lifton, R. P. (1998) Curr. Opin. Cell Biol. 10, 450-454[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Simon, D. B., Karet, F. E., Hamdan, J. M., DiPietro, A., Sanjad, S. A., and Lifton, R. P. (1996) Nat. Genet. 13, 183-188[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Simon, D. B., Bindra, R. S., Mansfield, T. A., Nelson-Williams, C., Mendonça, E., Stone, R., Schurman, S., Nayir, A., Alpay, H., Bakkaloglu, A., Rodriguez-Soriano, J., Morales, J. M., Sanjad, S. A., Taylor, C. M., Pilz, D., Brem, A., Trachtman, H., Griswold, W., Richard, G. A., John, E., and Lifton, R. P. (1997) Nat. Genet. 17, 171-178[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Estevez, R., Boettger, T., Stein, V., Birkenhager, R., Otto, E., Hildebrandt, F., and Jentsch, T. J. (2001) Nature 414, 558-561[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Birkenhager, R., Otto, E., Schurmann, M. J., Vollmer, M., Ruf, E. M., Maier-Lutz, I., Beekmann, F., Fekete, A., Omran, H., Feldmann, D., Milford, D. V., Jeck, N., Konrad, M., Landau, D., Knoers, N. V., Antignac, C., Sudbrak, R., Kispert, A., and Hildebrandt, F. (2001) Nat. Genet. 29, 310-314[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Simon, D. B., Karet, F. E., Rodriguez-Soriano, J., Hamdan, J. H., DiPietro, A., Trachtman, H., Sanjad, S. A., and Lifton, R. P. (1996) Nat. Genet. 14, 152-156[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Karolyil, L., Konrad, M., Kockerling, A., Ziegler, A., Zimmermann, D. K., Roth, B., Wieg, C., Grzeschik, K.-H., Koch, M. C., Seyberth, H. W., Vargus, R., Forestier, L., Jean, G., Deschaux, M., Rizzoni, G. F., Niaudet, P., Antignac, C., Feldman, D., Lorridon, F., Cougoureux, E., Laroze, F., Alessandri, J.-L., David, L., Saunier, P., Deschenes, G., Hildebrandt, F., Vollmer, M., Proesmans, W., Brandis, M., van den Heuvell, L. P. W. J., Lemmink, H. H., Nillesen, W., Monnens, L. A. H., Knoers, N. V. A. M., Guay-Woodford, L. M., Wright, C. J., Madrigal, G., and Hebert, S. C. (1997) Hum. Mol. Genet. 6, 17-26[Medline] [Order article via Infotrieve] |
| 38. | Vollmer, M., Koehrer, M., Topaloglu, R., Strahm, B., Omran, H., and Hildebrandt, F. (1998) Pediatr. Nephrol. 12, 69-71[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Schwalbe, R. A.,
Bianchi, L.,
Accili, E. A.,
and Brown, A. M.
(1998)
Hum. Mol. Genet.
7,
975-980 |
| 40. | Derst, C., Konrad, M., Köckerling, A., Karschin, A., Daut, J., and Seyberth, H. W. (1997) Biochem. Biophys. Res. Commun. 230, 641-645[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Derst, C.,
Wischmeyer, E.,
Preisig-Muller, R.,
Spauschus, A.,
Konrad, M.,
Hensen, P.,
Jeck, N.,
Seyberth, H. W.,
Daut, J.,
and Karschin, A.
(1998)
J. Biol. Chem.
273,
23884-23891 |
| 42. |
Flagg, T. P.,
Tate, M.,
Merot, J.,
and Welling, P. A.
(1999)
J. Gen. Physiol.
114,
685-700 |
| 43. | Xu, J., Hall, A. E., Peterson, L. N., Bienkowski, M. J., Essalu, T. E., and Hebert, S. C. (1997) Am. J. Physiol. 273, F739-F748[Medline] [Order article via Infotrieve] |
| 44. | Biemesderfer, D., Rutherford, P. A., Nagy, T., Pizzonia, J. H., Abu-Alfa, A. K., and Aronson, P. S. (1997) Am. J. Physiol. 273, F289-F299[Medline] [Order article via Infotrieve] |
| 45. |
Ecelbarger, C. A.,
Kim, G. H.,
Knepper, M. A.,
Liu, J.,
Tate, M.,
Welling, P. A.,
and Wade, J. B.
(2001)
J. Am. Soc. Nephrol.
12,
10-18 |
| 46. | Wang, T., Yang, C. L., Abbiati, T., Schultheis, P. J., Shull, G. E., Giebisch, G., and Aronson, P. S. (1999) Am. J. Physiol. 277, F298-F302[Medline] [Order article via Infotrieve] |
| 47. |
Lu, M.,
MacGregor, G. G.,
Wang, W.,
and Giebisch, G.
(2000)
J. Gen. Physiol.
116,
299-310 |
| 48. |
Takahashi, N.,
Chernavvsky, D. R.,
Gomez, R. A.,
Igarashi, P.,
Gitelman, H. J.,
and Smithies, O.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5434-5439 |
| 49. | Lu, M., and Wang, W. (2000) Kidney Blood Press. Res. 23, 75-82[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Gill, J. R., Jr., and Bartter, F. C. (1978) Am. J. Med. 65, 766-772[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Tsukamoto, T., Kobayashi, T., Kawamoto, K., Fukase, M., and Chihara, K. (1995) Am. J. Kidney Dis. 25, 637-641[Medline] [Order article via Infotrieve] |
| 52. | Velazquez, H., and Wright, F. S. (1986) Am. J. Physiol. 250, F1013-F1023[Medline] [Order article via Infotrieve] |
| 53. | Good, D. W., and Wright, F. S. (1979) Am. J. Physiol. 236-5, F192-F205 |
| 54. | Wang, W., Sackin, H., and Giebisch, G. (1992) Annu. Rev. Physiol. 54, 81-96[CrossRef][Medline] [Order article via Infotrieve] |
| 55. |
Wang, W.,
and Giebisch, G.
(1991)
J. Gen. Physiol.
98,
35-61 |
| 56. | Frindt, G., and Palmer, L. G. (1989) Am. J. Physiol. 256, F143-F151[Medline] [Order article via Infotrieve] |
| 57. | Hebert, T. E., Loisel, T. P., Adam, L., Ethier, N., Onge, S. S., and Bouvier, M. (1998) Biochem. J. 330, 287-293[Medline] [Order article via Infotrieve] |
| 58. | Zolotnitskaya, A., and Satlin, L. M. (1999) Am. J. Physiol. 276, F825-F836[Medline] [Order article via Infotrieve] |
| 59. | Wang, W. (1994) Am. J. Physiol. 267, F599-F605[Medline] [Order article via Infotrieve] |
| 60. | Guggino, S. E., Guggino, W. B., Green, N., and Sacktor, B. (1987) Am. J. Physiol. 252, C121-C127[Medline] [Order article via Infotrieve] |
| 61. |
Lu, M.,
Zhu, Y.,
Balazy, M.,
Reddy, K. M.,
Falck, J. R.,
and Wang, W.-H.
(1996)
J. Gen. Physiol.
108,
537-547 |
| 62. |
Wang, W.,
and Lu, M.
(1995)
J. Gen. Physiol.
106,
727-743 |
| 63. | Frindt, G., and Palmer, L. G. (1987) Am. J. Physiol. 252, F458-F467[Medline] [Order article via Infotrieve] |
| 64. |
DeJongh, K. S.,
Warner, C.,
and Catterall, W. A.
(1990)
J. Biol. Chem.
265,
14738-14741 |
| 65. | Woda, C. B., Bragin, A., Kleyman, T. R., and Satlin, L. M. (2001) Am. J. Physiol. 280, F786-F793 |
| 66. | Taniguchi, J., and Imai, M. (1998) J. Membr. Biol. 164, 35-45[CrossRef][Medline] [Order article via Infotrieve] |
| 67. | Hropot, M., Fowler, N., Karlmark, B., and Giebisch, G. (1985) Kidney Int. 28, 477-489[Medline] [Order article via Infotrieve] |
| 68. | Velazquez, H., Ellison, D. H., and Wright, F. S. (1987) Am. J. Physiol. 253, F555-F562[Medline] [Order article via Infotrieve] |
| 69. |
Lorenz, J. N.,
Baird, N. R.,
Judd, L. M.,
Noonan, W. T.,
Andringa, A.,
Doetschman, T.,
Manning, P. A.,
Liu, L. H.,
Miller, M. L.,
and Shull, G. E.
(2002)
J. Biol. Chem.
277,
37871-37880 |
This article has been cited by other articles:
![]() |
A. Cantone, X. Yang, Q. Yan, G. Giebisch, S. C. Hebert, and T. Wang Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1366 - F1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alewine, B.-y. Kim, V. Hegde, and P. A. Welling Lin-7 targets the Kir 2.3 channel on the basolateral membrane via a L27 domain interaction with CASK Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1733 - C1741. [Abstract] [Full Text] [PDF] |
||||
![]() |